These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 34345946)

  • 1. Characterization of breast cancer subtypes based on quantitative assessment of intratumoral heterogeneity using dynamic contrast-enhanced and diffusion-weighted magnetic resonance imaging.
    Kim JJ; Kim JY; Suh HB; Hwangbo L; Lee NK; Kim S; Lee JW; Choo KS; Nam KJ; Kang T; Park H
    Eur Radiol; 2022 Feb; 32(2):822-833. PubMed ID: 34345946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triple-negative invasive breast cancer on dynamic contrast-enhanced and diffusion-weighted MR imaging: comparison with other breast cancer subtypes.
    Youk JH; Son EJ; Chung J; Kim JA; Kim EK
    Eur Radiol; 2012 Aug; 22(8):1724-34. PubMed ID: 22527371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histogram Analysis and Visual Heterogeneity of Diffusion-Weighted Imaging with Apparent Diffusion Coefficient Mapping in the Prediction of Molecular Subtypes of Invasive Breast Cancers.
    Horvat JV; Iyer A; Morris EA; Apte A; Bernard-Davila B; Martinez DF; Leithner D; Sutton OM; Ochoa-Albiztegui RE; Giri D; Pinker K; Thakur SB
    Contrast Media Mol Imaging; 2019; 2019():2972189. PubMed ID: 31819738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of dynamic contrast-enhanced MRI and diffusion-weighted MR imaging with prognostic factors and subtypes of breast cancers.
    Chen H; Li W; Wan C; Zhang J
    Front Oncol; 2022; 12():942943. PubMed ID: 35992872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric MRI Features of Breast Cancer Molecular Subtypes.
    Szep M; Pintican R; Boca B; Perja A; Duma M; Feier D; Fetica B; Eniu D; Dudea SM; Chiorean A
    Medicina (Kaunas); 2022 Nov; 58(12):. PubMed ID: 36556918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is simultaneous multi-slice readout-segmented echo-planar imaging valuable for predicting molecular subtypes of breast cancer?
    Li X; Zhu H; Sun K; Chai W; Fu C; Yan F
    Eur J Radiol; 2022 May; 150():110232. PubMed ID: 35259708
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiomic Signatures Derived from Diffusion-Weighted Imaging for the Assessment of Breast Cancer Receptor Status and Molecular Subtypes.
    Leithner D; Bernard-Davila B; Martinez DF; Horvat JV; Jochelson MS; Marino MA; Avendano D; Ochoa-Albiztegui RE; Sutton EJ; Morris EA; Thakur SB; Pinker K
    Mol Imaging Biol; 2020 Apr; 22(2):453-461. PubMed ID: 31209778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) mapping as a quantitative imaging biomarker for prediction of immunohistochemical receptor status, proliferation rate, and molecular subtypes of breast cancer.
    Horvat JV; Bernard-Davila B; Helbich TH; Zhang M; Morris EA; Thakur SB; Ochoa-Albiztegui RE; Leithner D; Marino MA; Baltzer PA; Clauser P; Kapetas P; Bago-Horvath Z; Pinker K
    J Magn Reson Imaging; 2019 Sep; 50(3):836-846. PubMed ID: 30811717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravoxel incoherent motion diffusion-weighted MRI of invasive breast cancer: Correlation with prognostic factors and kinetic features acquired with computer-aided diagnosis.
    Song SE; Cho KR; Seo BK; Woo OH; Park KH; Son YH; Grimm R
    J Magn Reson Imaging; 2019 Jan; 49(1):118-130. PubMed ID: 30238533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion Kurtosis MR Imaging of Invasive Breast Cancer: Correlations With Prognostic Factors and Molecular Subtypes.
    Kang HS; Kim JY; Kim JJ; Kim S; Lee NK; Lee JW; Suh HB; Hwangbo L; Son Y; Grimm R
    J Magn Reson Imaging; 2022 Jul; 56(1):110-120. PubMed ID: 34792837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination of DCE-MRI and NME-DWI via Deep Neural Network for Predicting Breast Cancer Molecular Subtypes.
    Ba ZC; Zhang HX; Liu AY; Zhou XX; Liu L; Wang XY; Nanding A; Sang XQ; Kuai ZX
    Clin Breast Cancer; 2024 Jul; 24(5):e417-e427. PubMed ID: 38555225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved discrimination of molecular subtypes in invasive breast cancer: Comparison of multiple quantitative parameters from breast MRI.
    Du S; Gao S; Zhang L; Yang X; Qi X; Li S
    Magn Reson Imaging; 2021 Apr; 77():148-158. PubMed ID: 33309922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Dynamic Contrast-Enhanced and Diffusion-Weighted Breast Magnetic Resonance Imaging Findings for Prediction of Lymphovascular Invasion of the Lesions in Node-Negative Invasive Breast Cancer.
    Coşkun Bilge A; Yaltırık Bilgin E; Bulut ZM; Esen Bostancı I; Bilgin E
    Can Assoc Radiol J; 2024 May; 75(2):386-396. PubMed ID: 38095635
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlations between diffusion-weighted imaging and breast cancer biomarkers.
    Martincich L; Deantoni V; Bertotto I; Redana S; Kubatzki F; Sarotto I; Rossi V; Liotti M; Ponzone R; Aglietta M; Regge D; Montemurro F
    Eur Radiol; 2012 Jul; 22(7):1519-28. PubMed ID: 22411304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.
    Liu S; Ren R; Chen Z; Wang Y; Fan T; Li C; Zhang P
    J Magn Reson Imaging; 2015 Sep; 42(3):779-87. PubMed ID: 25580585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk.
    Kim JY; Kim JJ; Hwangbo L; Lee JW; Lee NK; Nam KJ; Choo KS; Kang T; Park H; Son Y; Grimm R
    Eur Radiol; 2020 Jan; 30(1):66-76. PubMed ID: 31385051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiparametric MRI model with dynamic contrast-enhanced and diffusion-weighted imaging enables breast cancer diagnosis with high accuracy.
    Zhang M; Horvat JV; Bernard-Davila B; Marino MA; Leithner D; Ochoa-Albiztegui RE; Helbich TH; Morris EA; Thakur S; Pinker K
    J Magn Reson Imaging; 2019 Mar; 49(3):864-874. PubMed ID: 30375702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic Usefulness of Combination of Diffusion-weighted Imaging and T2WI, Including Apparent Diffusion Coefficient in Breast Lesions: Assessment of Histologic Grade.
    Kim KW; Kuzmiak CM; Kim YJ; Seo JY; Jung HK; Lee MS
    Acad Radiol; 2018 May; 25(5):643-652. PubMed ID: 29339079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between MRI findings and breast cancer subtypes: focused on the combination patterns on diffusion-weighted and T2-weighted images.
    Yuen S; Monzawa S; Yanai S; Matsumoto H; Yata Y; Ichinose Y; Deai T; Hashimoto T; Tashiro T; Yamagami K
    Breast Cancer; 2020 Sep; 27(5):1029-1037. PubMed ID: 32377938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative characterization of breast tumors with diffusion-weighted imaging has comparable accuracy to quantitative analysis.
    Kul S; Metin Y; Bekircavusoglu S; Kul M
    Clin Imaging; 2021 Sep; 77():17-24. PubMed ID: 33639496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.